Drug delivery and translational research

Zhou R, Yu J, Gu Z, Zhang Y.
PMID: 34637115
Drug Deliv Transl Res. 2021 Oct 12; doi: 10.1007/s13346-021-01073-7. Epub 2021 Oct 12.

Cardiovascular diseases remain a leading cause of global disease burden. To date, the limited drug delivery efficacy confines the therapeutic effect in most conventional approaches, such as intramyocardial injections and vascular devices, due to short-term drug release and low...

Drug delivery and translational research

Zhou R, Yu J, Gu Z, Zhang Y.
PMID: 34637115
Drug Deliv Transl Res. 2022 Feb;12(2):472-483. doi: 10.1007/s13346-021-01073-7. Epub 2021 Oct 12.

Cardiovascular diseases remain a leading cause of global disease burden. To date, the limited drug delivery efficacy confines the therapeutic effect in most conventional approaches, such as intramyocardial injections and vascular devices, due to short-term drug release and low...

Pharmaceutical research

Zhang W, Sheng T, Gu Z, Zhang Y.
PMID: 34398404
Pharm Res. 2021 Aug;38(8):1327-1334. doi: 10.1007/s11095-021-03081-1. Epub 2021 Aug 16.

Obesity expands as a global climbing epidemic that is often correlated to cardiovascular diseases and endocrine disorders. Converting white adipocytes to brown adipocytes for enhanced energy expenditure has recently emerged as a promising anti-obesity treatment. However, the conventional approaches...

Drug delivery and translational research

Zhou R, Yu J, Gu Z, Zhang Y.
PMID: 34637115
Drug Deliv Transl Res. 2022 Feb;12(2):472-483. doi: 10.1007/s13346-021-01073-7. Epub 2021 Oct 12.

Cardiovascular diseases remain a leading cause of global disease burden. To date, the limited drug delivery efficacy confines the therapeutic effect in most conventional approaches, such as intramyocardial injections and vascular devices, due to short-term drug release and low...